Group (n) | PGI (ng/ml) | PGII (ng/ml) | PGR | G-17 (mmol/l) | Hp (+) n (%) |
---|---|---|---|---|---|
Non atrophic gastritis group (655) | 130.34 ± 68.33 | 13.95 ± 7.74 | 10.68 ± 5.39 | 5.53 (2.95, 10.56) | 284 (43.36) |
Atrophic gastritis group (52) | 122.27 ± 52.77* | 18.84 ± 11.13* | 7.37 ± 2.78* | 5.53 (4.24, 9.02) | 26* (50.00) |
Gastric ulcer group (109) | 169.85 ± 84.51* | 20.09 ± 11.50* | 9.69 ± 4.85 | 5.96 (3.77, 11.25)* | 71* (65.14) |
Non-neoplastic polyp group (79) | 132.37 ± 62.39 | 19.37 ± 11.58* | 8.49 ± 5.62* | 6.39 (4.53, 10.95)* | 39 (49.37) |
Precancerous lesion group (94) | 109.70 ± 60.57* | 18.08 ± 10.49* | 6.95 ± 3.56* | 6.65 (4.06, 13.02)* | 58* (61.70) |
Early cancer group (12) | 98.61 ± 72.45* | 17.26 ± 5.81* | 6.13 ± 4.11* | 5.89 (4.96, 13.24)* | 7* (58.33) |
Advanced cancer group (15) | 66.30 ± 29.97* | 19.70 ± 8.84* | 4.54 ± 4.95* | 10.6 (4.83, 16.26)* | 10* (66.67) |
P | < 0.001 | < 0.001 | < 0.001 | 0.003 | < 0.001 |